Literature DB >> 9460258

Hepatocellular carcinoma in Brazil: report of a national survey (Florianópolis, SC, 1995).

C S Gonçalves1, F E Pereira, L C Gayotto.   

Abstract

In order to investigate epidemiological aspects of hepatocellular carcinoma (HCC) in Brazil, basic informations about cases diagnosed from January 1992 to December 1994 were requested to several medical centers of different Brazilian States. A simple questionnaire included age, sex, alcohol abuse (over 80g/day), associated liver cirrhosis, persistent HBV infection (HBsAg), HCV infection (anti-HCV) and serum levels of alpha fetoprotein. 287 cases, over 16 years old, from 19 medical centers of 8 States (Pará, Bahia, Minas Gerais, Espirito Santo, Rio de Janeiro, São Paulo, Paraná and Rio Grande do Sul) were analysed. The results showed: (a) Mean age was 56.3 +/- 14.4 for men and 54.7 +/- 16.8 yr for women and the male/female ratio was 3.4:1. (b) 69.6% were caucasians, 21.8% mullatoes, 4.8% orientals and 3.7% blacks. (c) HBsAg (+) in 77/236 cases (41.6%) without differences between males and females. (d) Anti-HCV (+) in 52/193 cases (26.9%). (e) 7/180 cases were positive both for HBsAg and anti-HCV (3.8%). (f) There was chronic alcoholism in 88/235 cases (37%). (g) HCC was found in cirrhotic livers in 71.2% of 202 cases in which the presence or absence of cirrhosis was reported. (h) Alpha-fetoprotein above 20 ng/ml was found in 124/172 cases (72%) and above 500 ng/ml only in 40 cases (23.2%). These results showed that the HCC in Brazil has an intermediate epidemiological pattern as compared to those from areas of low and high incidence of the tumor. In spite of the high frequency of the association of HCC with the HBV and/or HCV infections, 42% of 180 cases were negative both for HBsAg and anti-HCV, indicating the possible role of other etiological factors. The comparison of data from different States showed some regional differences: higher frequency of associated HBsAg in Pará, Bahia, Minas Gerais and Espírito Santo, higher frequency of associated HCV infection in Rio de Janeiro, São Paulo and States of the Southern region and low frequency of associated liver cirrhosis in Salvador and Rio de Janeiro (55.5 and 50% respectively). Further investigation will be necessary to study the presence of other possible etiological factors as aflatoxins, suggested by the favourable climatic conditions for food contamination by fungi in the majority Brazilian regions.

Entities:  

Mesh:

Year:  1997        PMID: 9460258     DOI: 10.1590/s0036-46651997000300008

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  9 in total

1.  Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.

Authors:  Fernanda Magri de Carvalho; Thiago de Almeida Pereira; Patrícia Lofego Gonçalves; Robson Dettmann Jarske; Fausto Edmundo Lima Pereira; Iuri Drumond Louro
Journal:  Mol Biol Rep       Date:  2013-05-07       Impact factor: 2.316

2.  Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil.

Authors:  Flair Jose Carrilho; Luciana Kikuchi; Fernanda Branco; Carlos Sandoval Goncalves; Angelo Aves de Mattos
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

3.  Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia.

Authors:  Fabian Cortes-Mancera; Carmen Luisa Loureiro; Sergio Hoyos; Juan-Carlos Restrepo; Gonzalo Correa; Sergio Jaramillo; Helene Norder; Flor Helene Pujol; Maria-Cristina Navas
Journal:  Hepat Res Treat       Date:  2011-09-20

4.  Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia.

Authors:  Maria-Cristina Navas; Iris Suarez; Andrea Carreño; Diego Uribe; Wilson Alfredo Rios; Fabian Cortes-Mancera; Ghyslaine Martel; Beatriz Vieco; Diana Lozano; Carlos Jimenez; Doriane Gouas; German Osorio; Sergio Hoyos; Juan Carlos Restrepo; Gonzalo Correa; Sergio Jaramillo; Rocio Lopez; Luis Eduardo Bravo; Maria Patricia Arbelaez; Jean-Yves Scoazec; Behnoush Abedi-Ardekani; Regina M Santella; Isabelle Chemin; Pierre Hainaut
Journal:  Hepat Res Treat       Date:  2011-10-31

5.  Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study.

Authors:  Ajacio B M Brandão; Sandra Costa Fuchs
Journal:  BMC Gastroenterol       Date:  2002-08-08       Impact factor: 3.067

6.  Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study.

Authors:  Marcelo Campos Appel-da-Silva; Suelen Aparecida da Silva Miozzo; Isabella de Azevedo Dossin; Cristiane Valle Tovo; Fernanda Branco; Angelo Alves de Mattos
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

7.  Epidemiological and Clinical Patterns of Newly Diagnosed Hepatocellular Carcinoma in Brazil: the Need for Liver Disease Screening Programs Based on Real-World Data.

Authors:  Gustavo Dos Santos Fernandes; Daniel Campos; Andre Ballalai; Rodrigo Palhares; Mario R A da Silva; Daniel M F Palhares; Ben-Hur F Neto; Fabio M do R Barros; Roberto de A Gil; Aline Chagas; Flair José Carrilho
Journal:  J Gastrointest Cancer       Date:  2021-09

8.  Etiology of liver cirrhosis in Brazil: chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Espírito Santo.

Authors:  Patricia Lofego Gonçalves; Maria da Penha Zago-Gomes; Carla Couzi Marques; Ana Tereza Mendonça; Carlos Sandoval Gonçalves; Fausto Edmundo Lima Pereira
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

9.  Aflatoxin B1 residues in human livers and their relationship with markers of hepatic carcinogenesis in São Paulo, Brazil.

Authors:  Leandra N Z Ramalho; Livia D Porta; Roice E Rosim; Tânia Petta; Marlei J Augusto; Deisy M Silva; Fernando S Ramalho; Carlos A F Oliveira
Journal:  Toxicol Rep       Date:  2018-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.